Drug Index

ERLOTINIB HYDROCHLORIDE

Generic: ERLOTINIB HYDROCHLORIDE

Review priority: STANDARD Marketing status: Discontinued

Route: ORAL
Class: General Medications
Safety profile: generic
Latest regulatory update: 22 Jun 2022, 12:00 am (UTC)

Structured Monograph

Approval overview ERLOTINIB HYDROCHLORIDE is listed in Drugs@FDA under application 216342 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient ERLOTINIB HYDROCHLORIDE Form and strength TABLET;ORAL - EQ 150MG BASE Sponsor EUGIA PHARMA Submission history Latest submission status date: 2022-06-22 00:00:00. Submission type: ORIG.